About this trial
Eligigble patients will be enrolled after obtaining informed consent. Basic information such as age, gender, body weight, smoking and alcohol history, number of gallstones, and gallbladder characteristics will be recorded.
During surgery, the method used to remove the gallbladder, the port used for extraction, and the duration of surgery will be documented. Any gallbladder perforation, leakage of bile, or spillage of gallstones during the procedure will also be recorded.
After surgery, patients will be monitored in the hospital for 24 hours. Their pain will be assessed before discharge. Patients will then be followed in the outpatient clinic for 10 days to assess wound healing and identify any wound infection or other complications.
The study aims to compare the safety and effectiveness of an improvised retrieval bag with removal of the gallbladder without a retrieval bag during laparoscopic surgery.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Elective Laparoscopic Cholecystectomy
Disqualifiers
Patients having common bile duct stones or dilatation
Acute cholecystitis, gallbladder perforation, malignancy (on medical record).
Patients requiring conversion to open cholecystectomy, ASA III-IV
Patients with skin diseases near wound site, diabetes (HbA1c>6.5%), and Hb <10gm/dl
Trial design
Parallel
Treatments tested in this trial
Endobag
DeviceGallbladder will be removed using Endobag
placebo group
DeviceGallbladder will be removed without using Endobag during Laparoscopic Cholecystectomy
Treatment groups
Trial outcomes
Primary outcomes
Surgical Time
Visible perforation of the gallbladder developed during gallbladder removal
Visible spillage of bile from the gallbladder during gallbladder removal
Visible spillage of gallstones from the gallbladder during gallbladder removal
Sponsors and contacts
Click on the lead sponsor to view all of their trials.